Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07Psilocybin or Nicotine Patch for Smoking CessationJAMA Network Open · 2026-03-10Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.The International journal on drug policy · 2026-02-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Practical considerations in the establishment of psychedelic research programs.Psychopharmacology · 2025-01-01Psychedelic Microdosing among Young Adults from Southern California.Journal of psychoactive drugs · 2025-01-01Amid magic and menace: psychiatrists' attitudes to psilocybin therapy.Irish journal of psychological medicine · 2024-11-07Psilocybin-assisted therapy and HIV-related shame.Scientific reports · 2024-08-02Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom.Psychological medicine · 2024-04-01IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.Pharmacological research · 2024-01-01Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.Journal of psychopharmacology (Oxford, England) · 2024-01-01Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.The American journal of psychiatry · 2024-01-01Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.Neuropharmacology · 2023-08-01Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.Journal of affective disorders · 2023-04-01Classic psychedelic use and current meditation practice.Mindfulness · 2023-04-01Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom useDrug Science Policy and Law · 2023-01-01Adapting psychedelic medicine for headache and chronic pain disorders.Expert review of neurotherapeutics · 2023-01-01Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development.Frontiers in psychology · 2023-01-01Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.Neuropharmacology · 2022-11-01Prevalence and associations of classic psychedelic-related seizures in a population-based sample.Drug and alcohol dependence · 2022-10-01Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.Neuropharmacology · 2022-08-15Classic psychedelics, health behavior, and physical health.Therapeutic advances in psychopharmacology · 2022-01-01Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.The International journal on drug policy · 2021-12-01Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year.Hypertension (Dallas, Tex.: 1979) · 2021-05-05Associations between lifetime classic psychedelic use and markers of physical health.Journal of psychopharmacology (Oxford, England) · 2021-04-01Psilocybin-assisted group therapy: A new hope for demoralization.EClinicalMedicine · 2020-10-01Accounting for Microdosing Classic PsychedelicsJournal of Drug Issues · 2019-08-30Narrative identity, rationality, and microdosing classic psychedelics.The International journal on drug policy · 2019-08-01Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.Pharmacology & therapeutics · 2019-05-01Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.Frontiers in psychiatry · 2019-01-01The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.Neuropharmacology · 2018-11-01Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.International review of psychiatry (Abingdon, England) · 2018-08-01The relationships of classic psychedelic use with criminal behavior in the United States adult population.Journal of psychopharmacology (Oxford, England) · 2018-01-01Psilocybin and palliative end-of-life care.Journal of psychopharmacology (Oxford, England) · 2016-12-01The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.Journal of psychoactive drugs · 2016-01-01Psilocybin, psychological distress, and suicidality.Journal of psychopharmacology (Oxford, England) · 2015-09-01Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.Journal of psychopharmacology (Oxford, England) · 2015-03-01Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.Journal of psychopharmacology (Oxford, England) · 2014-01-01